Cloning And Mutagenesis Global Market Report 2025 Market Revenue Is Expected To Reach $7.13 Billion By 2029
How Much Growth Is Anticipated In The Cloning And Mutagenesis Global Market Report 2025 Market Size From 2025 To 2034?
The cloning and mutagenesis market size has grown rapidly in recent years. It will grow from $2.98 billion in 2024 to $3.54 billion in 2025 at a compound annual growth rate (CAGR) of 18.7%. The growth in the historic period can be attributed to advancements in genetic research, increasing demand in pharmaceutical research, rise of genetic engineering in agriculture, biomedical research applications, pioneer applications in molecular biology.
The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $7.13 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to expanding applications in gene therapy, rising demand for personalized medicine, advancements in functional genomics, innovations in synthetic biology, application in agricultural biotechnology. Major trends in the forecast period include targeted gene editing in therapeutics, enhanced precision and specificity, customizable molecular tools, expanded applications in agriculture, ethical and regulatory considerations.
Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp
What Essential Growth Drivers Are Pushing The Cloning And Mutagenesis Global Market Report 2025 Market Forward?
Rising demand for genetically modified products is expected to propel the growth of the cloning and mutagenesis market going forward. Genetically modified product refers to any organism, material, or substance that has been modified by genetic engineering techniques by deliberate manipulation of an organism’s genes to introduce new traits or characteristics. Cloning is a scientific process for producing exact genetic clones for different living species, resistant to insects and plants, and in medical sciences for gene therapy, so the rising demand for genetically modified products will support the growth of the cloning and mutagenesis market. For instance, in February 2023, according to the data imparted in the annual report published by Bayar AG, a Germany-based biotechnology and pharmaceutical company, the annual sales of crop sciences and pharmaceutical segment that includes genetically modified products, has increased significantly over 2021, where the annual sales of crop sciences segment reached to $27,794.38 million in 2022, from $22,314.79 million in 2021. Therefore, the rising demand for genetically modified products is driving the growth of the cloning and mutagenesis market.
Which Segment Groups Play A Crucial Role In Outlining The Cloning And Mutagenesis Global Market Report 2025 Market’s Structure?
The cloning and mutagenesismarket covered in this report is segmented —
1) By Product: Cloning Kits, Mutagenesis Kits, Other Product
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End User
Subsegments:
1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits
2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits
3) By Other Products: Enzymes, Vector Systems, Accessories
What Trends Are Driving Change Across The Cloning And Mutagenesis Global Market Report 2025 Market Landscape?
Major companies operating in the cloning and mutagenesis market are developing advanced technologies such as bacteriophage genome modifying technologies to gain a competitive edge in the market. Bacteriophage genome modifying technologies refer to methods and tools used to intentionally alter the genetic material of bacteriophages, viruses that infect bacteria, for various research, therapeutic, or industrial applications. For instance, in October 2022, iNtRON Biotechnology, a South Korea-based biotechnology company, launched its 2nd generation technology for Robot Bacteriophage. This technology involves the use of random transposon mutagenesis, allowing the modification of the bacteriophage genome. This advancement, in addition to the previously developed customized CRISPR/Cas system, enables the identification and removal of non-essential genes in the bacteriophage genome. The company aims to freely design and produce bacteriophages with desired characteristics, facilitating the development of immunotherapeutic agents and antiviral solutions.
Which Companies Represent The Key Strategic Forces Within The Cloning And Mutagenesis Global Market Report 2025 Market?
Major companies operating in the cloning and mutagenesis market include Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.
Get Your In-Depth Cloning And Mutagenesis Global Market Report 2025 Market Report Now:
https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report
Which Regional Clusters Are Forecasted To Outperform Others In The Cloning And Mutagenesis Global Market Report 2025 Market?
North America was the largest region in the cloning and mutagenesis market in 2024.Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment